100 related articles for article (PubMed ID: 20198304)
1. Binding proteins internalized by PTD-fused ligands allow the intracellular sequestration of selected targets by ligand exchange.
Moosmeier MA; Bulkescher J; Hoppe-Seyler K; Hoppe-Seyler F
Int J Mol Med; 2010 Apr; 25(4):557-64. PubMed ID: 20198304
[TBL] [Abstract][Full Text] [Related]
2. The Role of Changing Loop Conformations in Streptavidin Versions Engineered for High-affinity Binding of the Strep-tag II Peptide.
Schmidt TGM; Eichinger A; Schneider M; Bonet L; Carl U; Karthaus D; Theobald I; Skerra A
J Mol Biol; 2021 Apr; 433(9):166893. PubMed ID: 33639211
[TBL] [Abstract][Full Text] [Related]
3. Non-covalent ligand conjugation to biotinylated DNA nanoparticles using TAT peptide genetically fused to monovalent streptavidin.
Sun W; Fletcher D; van Heeckeren RC; Davis PB
J Drug Target; 2012 Sep; 20(8):678-90. PubMed ID: 22845840
[TBL] [Abstract][Full Text] [Related]
4. Development of the Twin-Strep-tag® and its application for purification of recombinant proteins from cell culture supernatants.
Schmidt TG; Batz L; Bonet L; Carl U; Holzapfel G; Kiem K; Matulewicz K; Niermeier D; Schuchardt I; Stanar K
Protein Expr Purif; 2013 Nov; 92(1):54-61. PubMed ID: 24012791
[TBL] [Abstract][Full Text] [Related]
5. Cell surface adherence and endocytosis of protein transduction domains.
Lundberg M; Wikström S; Johansson M
Mol Ther; 2003 Jul; 8(1):143-50. PubMed ID: 12842437
[TBL] [Abstract][Full Text] [Related]
6. Protein transduction domains fused to virus receptors improve cellular virus uptake and enhance oncolysis by tumor-specific replicating vectors.
Kühnel F; Schulte B; Wirth T; Woller N; Schäfers S; Zender L; Manns M; Kubicka S
J Virol; 2004 Dec; 78(24):13743-54. PubMed ID: 15564483
[TBL] [Abstract][Full Text] [Related]
7. High resolution structure of streptavidin in complex with a novel high affinity peptide tag mimicking the biotin binding motif.
Perbandt M; Bruns O; Vallazza M; Lamla T; Betzel Ch; Erdmann VA
Proteins; 2007 Jun; 67(4):1147-53. PubMed ID: 17377987
[TBL] [Abstract][Full Text] [Related]
8. Intracellular protein delivery activity of peptides derived from insulin-like growth factor binding proteins 3 and 5.
Goda N; Tenno T; Inomata K; Shirakawa M; Tanaka T; Hiroaki H
Exp Cell Res; 2008 Aug; 314(13):2352-61. PubMed ID: 18602100
[TBL] [Abstract][Full Text] [Related]
9. Engineering Streptavidin and a Streptavidin-Binding Peptide with Infinite Binding Affinity and Reversible Binding Capability: Purification of a Tagged Recombinant Protein to High Purity via Affinity-Driven Thiol Coupling.
Fogen D; Wu SC; Ng KK; Wong SL
PLoS One; 2015; 10(9):e0139137. PubMed ID: 26406477
[TBL] [Abstract][Full Text] [Related]
10. TAT-mediated aequorin transduction: an alternative approach for effective calcium measurements in plant cells.
Zonin E; Moscatiello R; Miuzzo M; Cavallarin N; Di Paolo ML; Sandonà D; Marin O; Brini M; Negro A; Navazio L
Plant Cell Physiol; 2011 Dec; 52(12):2225-35. PubMed ID: 22025557
[TBL] [Abstract][Full Text] [Related]
11. Stable, high-affinity streptavidin monomer for protein labeling and monovalent biotin detection.
Lim KH; Huang H; Pralle A; Park S
Biotechnol Bioeng; 2013 Jan; 110(1):57-67. PubMed ID: 22806584
[TBL] [Abstract][Full Text] [Related]
12. Multivalent interactions between streptavidin-based pretargeting fusion proteins and cell receptors impede efficient internalization of biotinylated nanoparticles.
Parker CL; Yang Q; Yang B; McCallen JD; Park SI; Lai SK
Acta Biomater; 2017 Nov; 63():181-189. PubMed ID: 28870833
[TBL] [Abstract][Full Text] [Related]
13. Internalization of novel non-viral vector TAT-streptavidin into human cells.
Rinne J; Albarran B; Jylhävä J; Ihalainen TO; Kankaanpää P; Hytönen VP; Stayton PS; Kulomaa MS; Vihinen-Ranta M
BMC Biotechnol; 2007 Jan; 7():1. PubMed ID: 17199888
[TBL] [Abstract][Full Text] [Related]
14. A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells.
Albarran B; To R; Stayton PS
Protein Eng Des Sel; 2005 Mar; 18(3):147-52. PubMed ID: 15820981
[TBL] [Abstract][Full Text] [Related]
15. Control of protein trafficking by reversible masking of transport signals.
Abraham O; Gotliv K; Parnis A; Boncompain G; Perez F; Cassel D
Mol Biol Cell; 2016 Apr; 27(8):1310-9. PubMed ID: 26941332
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of HIV-Tat protein transduction domain.
Yoon JS; Jung YT; Hong SK; Kim SH; Shin MC; Lee DG; Shin WS; Min WS; Paik SY
J Microbiol; 2004 Dec; 42(4):328-35. PubMed ID: 15650690
[TBL] [Abstract][Full Text] [Related]
17. New transport peptides broaden the horizon of applications for peptidic pharmaceuticals.
Langedijk JP; Olijhoek T; Schut D; Autar R; Meloen RH
Mol Divers; 2004; 8(2):101-11. PubMed ID: 15209161
[TBL] [Abstract][Full Text] [Related]
18. Cellular uptake and lysosomal delivery of galactocerebrosidase tagged with the HIV Tat protein transduction domain.
Zhang XY; Dinh A; Cronin J; Li SC; Reiser J
J Neurochem; 2008 Feb; 104(4):1055-64. PubMed ID: 17986221
[TBL] [Abstract][Full Text] [Related]
19. Molecular interaction between the Strep-tag affinity peptide and its cognate target, streptavidin.
Schmidt TG; Koepke J; Frank R; Skerra A
J Mol Biol; 1996 Feb; 255(5):753-66. PubMed ID: 8636976
[TBL] [Abstract][Full Text] [Related]
20. Effects of protein transduction domain (PTD) selection and position for improved intracellular delivery of PTD-Hsp27 fusion protein formulations.
Ul Ain Q; Lee JH; Woo YS; Kim YH
Arch Pharm Res; 2016 Sep; 39(9):1266-74. PubMed ID: 27381220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
